Biosimilar White Papers

  1. The End Of End Point Assays: How SPR Is Changing Analytics In Vaccine Design And Development 2/18/2021

    Discover how SPR can be used to accelerate vaccine discovery and development by helping overcome analytical challenges that have plagued the industry for decades.

  2. Identifying Enhanced Needle Solutions & Integrated System Solutions To Serve The Chronic Disease Market 7/17/2020

    In addition to wider uptake of home care, an increase in the number of biologics being manufactured, many by the same company, is driving ongoing innovation in drug delivery systems. Identifying enhanced needle solutions and offering integrated system solutions to serve the chronic disease market is a great step toward addressing improved patient outcomes and adherence.

  3. Integrated Tools For Upstream Process Intensification: Part I 10/27/2019

    Changes to bioprocessing methodologies in the biopharmaceutical industry are being driven by the need for increased speed, a lower cost of goods (COGs), and greater flexibility.

  4. Scaling A mAb Production Process To A Single-Use Platform 9/27/2019

    The transfer of mAb production processes between scales, referred to as scale-up or scale-down, is difficult. This study reviews moving mAb production from a microscale bioreactor to a single-use platform.

  5. Tumor-Infiltrating Lymphocytes: What, Why, And How 7/1/2020

    As we explore immune mechanisms using technology, we find better ways to fight disease. Here, we focus on targeted, highly personalized cancer therapies called tumor-infiltrating lymphocytes.

  6. Addressing The Evolving Needs Of Variable Drug Delivery Regimens 9/14/2020

    Pharmaceutical companies continue to advance their clinical development pipelines to develop new and more sophisticated biologics. To be successful, they will need a solution that will enable the delivery and successful commercialization of complex biologics. This article describes a device designed specifically to address the rapidly evolving needs of the pharma industry and meet patient requirements.

  7. Key Concepts Driving The Future Of Single-Use In Biopharma Production 7/31/2019

    This article discusses four topics related to single-use bioprocessing which are commonly cited by end users as amenable to future development. 

  8. Cell Based Potency Assay In Functional Characterization Of Therapeutic mAbs 6/12/2019

    Because characterization and comparison of originator and biosimilar candidate mAbs is challenging due to their complex and variable structures, a range of analytical techniques should be emoloyed.

  9. 2D And 3D Pre-Designed Solutions For Storage And Shipping 3/18/2019

    Single-use in cGMP production requires enhanced assurance of supply and product performance. Innovative bioprocessing bag technology meets these challenges for every process step and application.

  10. How Buffer pH And NaCl Affect Size Exclusion Chromatography 4/22/2020

    Using a design of experiments approach, this study describes the effect of buffer pH and NaCl concentration on proteins purified by size exclusion chromatography.